References
- Altenburg, A. F., Rimmelzwaan, G. F., & de Vries, R. D. (2015). Virus-specific T cells as correlate of (cross-)protective immunity against influenza. Vaccine, 33(4), 500–506. https://doi.org/https://doi.org/10.1016/j.vaccine.2014.11.054
- Antonets, D. V., & Bazhan, S. I. (2013). PolyCTLDesigner: A computational tool for constructing polyepitope T-cell antigens. BMC Research Notes, 6(1), 407. https://doi.org/https://doi.org/10.1186/1756-0500-6-407
- Antonets, D. V., & Maksyutov, A. Z. (2010). TEpredict: Software for T-Cell epitope prediction. Molecular Biology, 44(1), 119–127. https://doi.org/https://doi.org/10.1134/s0026893310010152
- Barouch, D. H., Stephenson, K. E., Borducchi, E. N., Smith, K., Stanley, K., McNally, A. G., Liu, J., Abbink, P., Maxfield, L. F., Seaman, M. S., Dugast, A.-S., Alter, G., Ferguson, M., Li, W., Earl, P. L., Moss, B., Giorgi, E. E., Szinger, J. J., Eller, L. A., … Michael, N. L. (2013). Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys. Cell, 155(3), 531–539. https://doi.org/https://doi.org/10.1016/j.cell.2013.09.061
- Bates, D., Chambers, J., Dalgaard, P., Gentleman, R., Hornik, K., Ihaka, R., & Urbanek, S. (2020). R Development Core Team. R: A language and environment for statistical computing. The R Foundation for Statistical Computing. https://www.r-project.org/
- Bazhan, S. I., Karpenko, L. I., Ilyicheva, T. N., Belavin, P. A., Seregin, S. V., Danilyuk, N. K., Antonets, D. V., & Ilyichev, A. A. (2010). Rational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+ T cell responses . Molecular Immunology, 47(7-8), 1507–1515. https://doi.org/https://doi.org/10.1016/j.molimm.2010.01.020
- Bodewes, R., Kreijtz, J. H. C. M., Geelhoed-Mieras, M. M., van Amerongen, G., Verburgh, R. J., van Trierum, S. E., Kuiken, T., Fouchier, R. A. M., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2011). Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. Journal of Virology, 85(6), 2695–2702. https://doi.org/https://doi.org/10.1128/jvi.02371-10
- Cardinaud, S., Bouziat, R., Rohrlich, P.-S., Tourdot, S., Weiss, L., Langlade-Demoyen, P., Burgevin, A., Fiorentino, S., van Endert, P., & Lemonnier, F. A. (2009). Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct. AIDS (London, England)), 23(15), 1945–1954. https://doi.org/https://doi.org/10.1097/QAD.0b013e32832fae88
- De Marco, D., Clementi, N., Mancini, N., Solforosi, L., Moreno, G. J., Sun, X., Tumpey, T. M., Gubareva, L. V., Mishin, V., Clementi, M., & Burioni, R. (2012). A Non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses. Plos One, 7(4), e34415. https://doi.org/https://doi.org/10.1371/journal.pone.0034415
- de Vries, R. D., Altenburg, A. F., & Rimmelzwaan, G. F. (2015). Universal influenza vaccines, science fiction or soon reality? Expert Review of Vaccines, 14(10), 1299–1301. https://doi.org/https://doi.org/10.1586/14760584.2015.1060860
- Deml, L., Bojak, A., Steck, S., Graf, M., Wild, J., Schirmbeck, R., Wolf, H., & Wagner, R. (2001). Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. Journal of Virology, 75(22), 10991–11001. https://doi.org/https://doi.org/10.1128/jvi.75.22.10991-11001.2001
- Depla, E., Van der Aa, A., Livingston, B. D., Crimi, C., Allosery, K., De Brabandere, V., Krakover, J., Murthy, S., Huang, M., Power, S., Babé, L., Dahlberg, C., McKinney, D., Sette, A., Southwood, S., Philip, R., Newman, M. J., & Meheus, L. (2008). Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections. Journal of Virology, 82(1), 435–450. https://doi.org/https://doi.org/10.1128/JVI.01505-07
- Dorosti, H., Eslami, M., Negahdaripour, M., Ghoshoon, M. B., Gholami, A., Heidari, R., Dehshahri, A., Erfani, N., Nezafat, N., & Ghasemi, Y. (2019). Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine. Journal of Biomolecular Structure & Dynamics, 37(13), 3524–3535. https://doi.org/https://doi.org/10.1080/07391102.2018.1519460
- Fischer, W., Perkins, S., Theiler, J., Bhattacharya, T., Yusim, K., Funkhouser, R., Kuiken, C., Haynes, B., Letvin, N. L., Walker, B. D., Hahn, B. H., & Korber, B. T. (2007). Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nature Medicine, 13(1), 100–106. https://doi.org/https://doi.org/10.1038/nm1461
- Gottlieb, T., & Ben-Yedidia, T. (2014). Epitope-based approaches to a universal influenza vaccine. Journal of Autoimmunity, 54, 15–20. https://doi.org/https://doi.org/10.1016/j.jaut.2014.07.005
- Guarnieri, F. G., Arterburn, L. M., Penno, M. B., Cha, Y., & August, J. T. (1993). The motif Tyr-X-X-hydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein 1. The Journal of Biological Chemistry, 268(3), 1941–1946.
- Hashem, A. M. (2015). Prospects of HA-based universal influenza vaccine. BioMed Research International, 2015, 414637. https://doi.org/https://doi.org/10.1155/2015/414637
- Hillaire, M. L. B., Osterhaus, A., & Rimmelzwaan, G. F. (2011). Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines. Journal of Biomedicine & Biotechnology, 2011, 939860. https://doi.org/https://doi.org/10.1155/2011/939860
- Hopp, T. P., & Woods, K. R. (1981). Prediction of protein antigenic determinants from amino acid sequences. Proceedings of the National Academy of Sciences of the United States of America, 78(6), 3824–3828. https://doi.org/https://doi.org/10.1073/pnas.78.6.3824
- Karpenko, L. I., Bazhan, S. I., Antonets, D. V., & Belyakov, I. M. (2014). Novel approaches in polyepitope T-cell vaccine development against HIV-1. Expert Review of Vaccines, 13(1), 155–173. https://doi.org/https://doi.org/10.1586/14760584.2014.861748
- Kassambara, A., Kosinski, M., Biecek, P., & Fabian, S. (2017). Survminer: Drawing survival curves using “ggplot2”. R package version 0.3.1. https://CRAN.R-project.org/package=survminer
- Kim, S. H., Paldurai, A., & Samal, S. K. (2017). A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus. Virology, 503, 31–36. https://doi.org/https://doi.org/10.1016/j.virol.2017.01.006
- Koutsakos, M., Illing, P. T., Nguyen, T. H. O., Mifsud, N. A., Crawford, J. C., Rizzetto, S., Eltahla, A. A., Clemens, E. B., Sant, S., Chua, B. Y., Wong, C. Y., Allen, E. K., Teng, D., Dash, P., Boyd, D. F., Grzelak, L., Zeng, W., Hurt, A. C., Barr, I., … Kedzierska, K. (2019). Human CD8+ T cell cross-reactivity across influenza A, B and C viruses . Nature Immunology, 20(5), 613–625. https://doi.org/https://doi.org/10.1038/s41590-019-0320-6
- Krammer, F., & Palese, P. (2015). Advances in the development of influenza virus vaccines. Nature Reviews. Drug Discovery, 14(3), 167–182. https://doi.org/https://doi.org/10.1038/nrd4529
- Kreijtz, J., Bodewes, R., van Amerongen, G., Kuiken, T., Fouchier, R. A. M., Osterhaus, A., & Rimmelzwaan, G. F. (2007). Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine, 25(4), 612–620. https://doi.org/https://doi.org/10.1016/j.vaccine.2006.08.036
- Kreijtz, J. H. C. M., Süzer, Y., Bodewes, R., Schwantes, A., van Amerongen, G., Verburgh, R. J., de Mutsert, G., van den Brand, J., van Trierum, S. E., Kuiken, T., Fouchier, R. A. M., Osterhaus, A. D. M. E., Sutter, G., & Rimmelzwaan, G. F. (2010). Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model. The Journal of General Virology, 91(Pt 11), 2745–2752. https://doi.org/https://doi.org/10.1099/vir.0.024885-0
- Kutzler, M. A., & Weiner, D. B. (2008). DNA vaccines: Ready for prime time? Nature Reviews. Genetics, 9(10), 776–788. https://doi.org/https://doi.org/10.1038/nrg2432
- Lafuente, E. M., & Reche, P. A. (2009). Prediction of MHC-peptide binding: A systematic and comprehensive overview. Current Pharmaceutical Design, 15(28), 3209–3220. https://doi.org/https://doi.org/10.2174/138161209789105162
- Lambert, N. D., Ovsyannikova, I. G., Pankratz, V. S., Jacobson, R. M., & Poland, G. A. (2012). Understanding the immune response to seasonal influenza vaccination in older adults: A systems biology approach. Expert Review of Vaccines, 11(8), 985–994. https://doi.org/https://doi.org/10.1586/erv.12.61
- Liao, W. W. P., & Arthur, J. W. (2011). Predicting peptide binding to Major Histocompatibility Complex molecules. Autoimmunity Reviews, 10(8), 469–473. https://doi.org/https://doi.org/10.1016/j.autrev.2011.02.003
- Livingston, B. D., Newman, M., Crimi, C., McKinney, D., Chesnut, R., & Sette, A. (2001). Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine, 19(32), 4652–4660. https://doi.org/https://doi.org/10.1016/S0264-410X(01)00233-X
- Lundegaard, C., Lamberth, K., Harndahl, M., Buus, S., Lund, O., & Nielsen, M. (2008). NetMHC-3.0: Accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Research, 36(Web Server issue), W509–W512. https://doi.org/https://doi.org/10.1093/nar/gkn202
- Mallajosyula, V. V. A., Citron, M., Ferrara, F., Lu, X., Callahan, C., Heidecker, G. J., Sarma, S. P., Flynn, J. A., Temperton, N. J., Liang, X., & Varadarajan, R. (2014). Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection. Proceedings of the National Academy of Sciences of the United States of America, 111(25), E2514–E2523. https://doi.org/https://doi.org/10.1073/pnas.1402766111
- McMichael, A. J., & Haynes, B. F. (2012). Lessons learned from HIV-1 vaccine trials: New priorities and directions. Nature Immunology, 13(5), 423–427. https://doi.org/https://doi.org/10.1038/ni.2264
- Neefjes, J., Jongsma, M. L. M., Paul, P., & Bakke, O. (2011). Towards a systems understanding of MHC class i and MHC class II antigen presentation. Nature Reviews. Immunology, 11(12), 823–836. https://doi.org/https://doi.org/10.1038/nri3084
- Osorio, D., Rondon-Villarreal, P., Torres, R. (n.d.). Peptides: Calculate indices and theoretical properties of protein sequences. R Package Version 1.1.1. https://cran.r-project.org/web/packages/Peptides/Peptides.pdf
- Pages, H., Aboyoun, P., Gentleman, R., DebRoy, S. (2017). Biostrings: String objects representing biological sequences, and matching algorithms. R package version 2.45.2. http://www.citeulike.org/user/heliopais/article/11644278
- Peters, B., Bulik, S., Tampe, R., Van Endert, P. M., & Holzhütter, H. G. (2003). Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. Journal of Immunology (Baltimore, Md. : 1950)), 171(4), 1741–1749. https://doi.org/https://doi.org/10.4049/jimmunol.171.4.1741
- Peters, B., Tong, W., Sidney, J., Sette, A., & Weng, Z. (2003). Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics (Oxford, England)), 19(14), 1765–1772. https://doi.org/https://doi.org/10.1093/bioinformatics/btg247
- Petersen, T. N., Brunak, S., von Heijne, G., & Nielsen, H. (2011). SignalP 4.0: Discriminating signal peptides from transmembrane regions. Nature Methods, 8(10), 785–786. https://doi.org/https://doi.org/10.1038/nmeth.1701
- Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/https://doi.org/10.1002/jcc.20084
- Petkov, S., Starodubova, E., Latanova, A., Kilpeläinen, A., Latyshev, O., Svirskis, S., Wahren, B., Chiodi, F., Gordeychuk, I., & Isaguliants, M. (2018). DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response. Plos One, 13(6), e0197902. https://doi.org/https://doi.org/10.1371/journal.pone.0197902
- Pica, N., & Palese, P. (2013). Toward a universal influenza virus vaccine: Prospects and challenges. In C. T. Caskey (Ed.), Annual review of medicine (Vol. 64, pp. 189–202). Palo Alto, CA : Annual Reviews. https://doi.org/https://doi.org/10.1146/annurev-med-120611-145115
- Prokopyeva, E. A., Sobolev, I. A., Prokopyev, M. V., & Shestopalov, A. M. (2016). Adaptation of influenza A(H1N1)pdm09 virus in experimental mouse models. Infection, Genetics and Evolution: journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 39, 265–271. https://doi.org/https://doi.org/10.1016/j.meegid.2016.01.022
- Reed, L. J., & Muench, H. (1938). A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology, 27(3), 493–497. https://doi.org/https://doi.org/10.1093/oxfordjournals.aje.a118408
- Reguzova, A., Antonets, D., Karpenko, L., Ilyichev, A., Maksyutov, R., & Bazhan, S. (2015). Design and evaluation of optimized artificial HIV-1 Poly-T cell-epitope immunogens. Plos One, 10(3)doi:, e0116412. 1371/journal.pone.0116412
- Rowell, J. F., Ruff, A. L., Guarnieri, F. G., Staveley-O'Carroll, K., Lin, X., Tang, J., & Siliciano, R. F. (1995). Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells. Journal of Immunology, 155(4), 1818–1828.
- Rudolph, M. G., Stanfield, R. L., & Wilson, I. A. (2006). How TCRs bind MHCs, peptides, and coreceptors. Annual Review of Immunology, 24, 419–466. https://doi.org/https://doi.org/10.1146/annurev.immunol.23.021704.115658
- Sabetian, S., Nezafat, N., Dorosti, H., Zarei, M., & Ghasemi, Y. (2019). Exploring dengue proteome to design an effective epitope-based vaccine against dengue virus. Journal of Biomolecular Structure & Dynamics, 37(10), 2546–2563. https://doi.org/https://doi.org/10.1080/07391102.2018.1491890
- Sardesai, N. Y., & Weiner, D. B. (2011). Electroporation delivery of DNA vaccines: Prospects for success. Current Opinion in Immunology, 23(3), 421–429. https://doi.org/https://doi.org/10.1016/j.coi.2011.03.008
- Schneider, S. C., Ohmen, J., Fosdick, L., Gladstone, B., Guo, J., Ametani, A., Sercarz, E. E., & Deng, H. (2000). Cutting edge: Introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display. Journal of Immunology (Baltimore, Md: 1950)), 165(1), 20–23. https://doi.org/https://doi.org/10.4049/jimmunol.165.1.20
- Schubert, B., & Kohlbacher, O. (2016). Designing string-of-beads vaccines with optimal spacers. Genome Medicine, 8(1), 1–10. https://doi.org/https://doi.org/10.1186/s13073-016-0263-6
- Singh, H., & Raghava, G. P. S. (2001). ProPred: Prediction of HLA-DR binding sites. Bioinformatics (Oxford, England)), 17(12), 1236–1237. https://doi.org/https://doi.org/10.1093/bioinformatics/17.12.1236
- Sridhar, S., Begom, S., Bermingham, A., Hoschler, K., Adamson, W., Carman, W., Bean, T., Barclay, W., Deeks, J. J., & Lalvani, A. (2013). Cellular immune correlates of protection against symptomatic pandemic influenza. Nature Medicine, 19(10), 1305–1312. https://doi.org/https://doi.org/10.1038/nm.3350
- Srivastava, S., Kamthania, M., Kumar Pandey, R., Kumar Saxena, A., Saxena, V., Kumar Singh, S., Kumar Sharma, R., & Sharma, N. (2019). Design of novel multi-epitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamics. Journal of Biomolecular Structure & Dynamics, 37(16), 4345–4360. https://doi.org/https://doi.org/10.1080/07391102.2018.1548977
- Tao, W. Q., & Gill, H. S. (2015). M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection. Vaccine, 33(20), 2307–2315. https://doi.org/https://doi.org/10.1016/j.vaccine.2015.03.063
- Therneau, T. M. (2016). A package for survival analysis in S. version 2.39-5. https://CRAN.R-project.org/package=survival
- Thomas, P. G., Keating, R., Hulse-Post, D. J., & Doherty, P. C. (2006). Cell-mediated protection in influenza infection. Emerging Infectious Diseases, 12(1), 48–54. https://doi.org/https://doi.org/10.3201/eid1201.051237
- Toes, R. E., Nussbaum, A. K., Degermann, S., Schirle, M., Emmerich, N. P., Kraft, M., Laplace, C., Zwinderman, A., Dick, T. P., Müller, J., Schönfisch, B., Schmid, C., Fehling, H. J., Stevanovic, S., Rammensee, H. G., & Schild, H. (2001). Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. The Journal of Experimental Medicine, 194(1), 1–12. https://doi.org/https://doi.org/10.1084/jem.194.1.1
- Uebel, S., Wiesmüller, K. H., Jung, G., & Tampé, R. (1999). Peptide libraries in cellular immune recognition. Current Topics in Microbiology and Immunology, 243, 1–21. https://doi.org/https://doi.org/10.1007/978-3-642-60142-2_1
- van de Weijer, M. L., Luteijn, R. D., & Wiertz, E. J. H. J. (2015). Viral immune evasion: Lessons in MHC class I antigen presentation. Seminars in Immunology, 27(2), 125–137. https://doi.org/https://doi.org/10.1016/j.smim.2015.03.010
- Varshavsky, A., Turner, G., Du, F., & Xie, Y. (2000). Felix Hoppe-Seyler lecture 2000. The ubiquitin system and the N-end rule pathway . Biological Chemistry, 381(9-10), 779–789. https://doi.org/https://doi.org/10.1515/BC.2000.101
- Villalobos, A., Welch, M., & Minshull, J. (2012). In silico design of functional DNA constructs. Methods in Molecular Biology (Clifton, N.J.), ( 852, 197–213. https://doi.org/https://doi.org/10.1007/978-1-61779-564-0_15
- Vita, R., Overton, J. A., Greenbaum, J. A., Ponomarenko, J., Clark, J. D., Cantrell, J. R., Wheeler, D. K., Gabbard, J. L., Hix, D., Sette, A., & Peters, B. (2015). The immune epitope database (IEDB) 3.0. Nucleic Acids Research, 43(Database issue), D405–D412. https://doi.org/https://doi.org/10.1093/nar/gku938
- Wang, W., Li, R., Deng, Y., Lu, N., Chen, H., Meng, X., Wang, W., Wang, X., Yan, K., Qi, X., Zhang, X., Xin, W., Lu, Z., Li, X., Bian, T., Gao, Y., Tan, W., & Ruan, L. (2015). Protective efficacy of the conserved NP, PB1, and M1 proteins as immunogens in DNA- and vaccinia virus-based universal influenza A virus vaccines in mice. Clinical and Vaccine Immunology : Cvi, 22(6), 618–630. https://doi.org/https://doi.org/10.1128/cvi.00091-15
- Webb, B., & Sali, A. (2016). Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics, 54(1), 5–6. doi:https://doi.org/10.1002/cpbi.3
- Wilkinson, T. M., Li, C. K. F., Chui, C. S. C., Huang, A. K. Y., Perkins, M., Liebner, J. C., Lambkin-Williams, R., Gilbert, A., Oxford, J., Nicholas, B., Staples, K. J., Dong, T., Douek, D. C., McMichael, A. J., & Xu, X.-N. (2012). Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nature Medicine, 18(2), 274–280. https://doi.org/https://doi.org/10.1038/nm.2612
- Wu, T. C., Guarnieri, F. G., Staveley-O'Carroll, K. F., Viscidi, R. P., Levitsky, H. I., Hedrick, L., Cho, K. R., August, J. T., & Pardoll, D. M. (1995). Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proceedings of the National Academy of Sciences of the United States of America, 92(25), 11671–11675. https://doi.org/https://doi.org/10.1073/pnas.92.25.11671
- Xu, K., Ling, Z.-Y., Sun, L., Xu, Y., Bian, C., He, Y., Lu, W., Chen, Z., & Sun, B. (2011). Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus. Viral Immunology, 24(1), 45–56. https://doi.org/https://doi.org/10.1089/vim.2010.0056
- Yassine, H. M., Boyington, J. C., McTamney, P. M., Wei, C.-J., Kanekiyo, M., Kong, W.-P., Gallagher, J. R., Wang, L., Zhang, Y., Joyce, M. G., Lingwood, D., Moin, S. M., Andersen, H., Okuno, Y., Rao, S. S., Harris, A. K., Kwong, P. D., Mascola, J. R., Nabel, G. J., & Graham, B. S. (2015). Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nature Medicine, 21(9), 1065–1070. https://doi.org/https://doi.org/10.1038/nm.3927
- Yewdell, J. W. (2011). DRiPs solidify: Progress in understanding endogenous MHC class I antigen processing. Trends in Immunology, 32(11), 548–558. https://doi.org/https://doi.org/10.1016/j.it.2011.08.001
- Zhang, Y., Aevermann, B. D., Anderson, T. K., Burke, D. F., Dauphin, G., Gu, Z., He, S., Kumar, S., Larsen, C. N., Lee, A. J., Li, X., Macken, C., Mahaffey, C., Pickett, B. E., Reardon, B., Smith, T., Stewart, L., Suloway, C., Sun, G., … Scheuermann, R. H. (2017). Influenza Research Database: An integrated bioinformatics resource for influenza virus research. Nucleic Acids Research, 45(D1), D466–D474. https://doi.org/https://doi.org/10.1093/nar/gkw857
- Zhu, H., Liu, K. C., Cerny, J., Imoto, T., & Moudgil, K. D. (2005). Insertion of the dibasic motif in the flanking region of a cryptic self-determinant leads to activation of the epitope-specific T cells. Journal of Immunology (Baltimore, Md.: 1950)), 175(4), 2252–2260. https://doi.org/https://doi.org/10.4049/jimmunol.175.4.2252